Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07014592 · ClinicalTrials.gov registry record · NA
Characterization and Analysis of Evoked Cortical Responses in Participants With Medication-intractable Epilepsy
A NA study of Intractable Epilepsy, sponsored by University of Michigan.
- Recruiting
- Registry status
- NA
- Development phase
- 5
- Enrollment target
- 1
- Study location
NCT07014592: Recruiting NA study of Intractable Epilepsy, sponsored by University of Michigan.
NCT07014592 is a NA study of Intractable Epilepsy that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07014592, a NA study of Intractable Epilepsy, is actively recruiting participants, sponsored by University of Michigan.
- RECRUITING
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this project is to study how the brain reacts to a small electrical signal. Researchers will be using a novel combination of recording electrodes. The researchers will measure the brain response from these electrodes.
Primary Outcome
From recording electrodes
Conditions Studied
Interventions
- DEVICE stimulating probes and electrodes
Study Locations (1)
Michigan
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2025-05-05 |
| Est. Completion | 2026-05 |
| Phase | NA |
What NCT07014592 shows while recruiting
NCT07014592 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Intractable Epilepsy appearing as the primary indexed condition, and to 1 intervention - of which stimulating probes and electrodes is the first listed.
NCT07014592 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT07014592 about?
NCT07014592 is a clinical study titled "Characterization and Analysis of Evoked Cortical Responses in Participants With Medication-intractable Epilepsy". The goal of this project is to study how the brain reacts to a small electrical signal. Researchers will be using a novel combination of recording electrodes. The researchers will measure the brain response from these electrodes.
What is the current status of trial NCT07014592?
This trial is currently recruiting. It is a NA study. The enrollment target is 5 participants. The study started on 2025-05-05. Estimated completion is 2026-05.
What conditions does trial NCT07014592 study?
This clinical trial studies the following conditions: Intractable Epilepsy.
What interventions are being tested in trial NCT07014592?
The interventions under investigation include: stimulating probes and electrodes (DEVICE).
Who is sponsoring clinical trial NCT07014592?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07014592 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Intractable Epilepsy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07014592's enrollment target sits among peer trials
5 1989th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI